Adamas Pharmaceuticals Inc·4

Jun 2, 4:40 PM ET

Adamas Pharmaceuticals Inc 4

4 · Adamas Pharmaceuticals Inc · Filed Jun 2, 2017

Insider Transaction Report

Form 4
Period: 2017-06-01
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-06-01+15,00015,000 total
    Exercise: $16.27Exp: 2027-05-31Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 1, 2017, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_728674

    POA DOCUMENT